Type 2 Diabetes does not worsen prognosis in hepatocellular carcinoma

Abstract

Introduction: Type 2 Diabetes (T2DM) is associated with liver inflammation and carcinogenesis. The prevalence of T2DM among patients with liver cirrhosis and hepatocellular carcinoma is increasing. However, the effect of T2DM on the natural history of hepatocellular carcinoma is not known. Aim: To examine the effect of T2DM on hepatocellular carcinoma (HCC) survival in treated and untreated disease. Methods: Retrospective analysis was performed on HCC cases diagnosed during 2000–2005, and prospectively during 2006–August 2007. Demographics, HCC staging, response to treatment, and survival were collected. A comparison was made between patients with T2DM and without T2DM. Results: One hundred ..